BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2723026)

  • 1. Treatment of orthostatic hypotension with octreotide.
    Hoeldtke RD; Israel BC
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1051-9. PubMed ID: 2723026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of orthostatic hypotension: interaction of pressor drugs and tilt table conditioning.
    Hoeldtke RD; Cavanaugh ST; Hughes JD
    Arch Phys Med Rehabil; 1988 Oct; 69(10):895-8. PubMed ID: 3178458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of orthostatic hypotension with midodrine and octreotide.
    Hoeldtke RD; Horvath GG; Bryner KD; Hobbs GR
    J Clin Endocrinol Metab; 1998 Feb; 83(2):339-43. PubMed ID: 9467537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR.
    Hoeldtke RD; Bryner KD; Hoeldtke ME; Hobbs G
    Clin Auton Res; 2007 Dec; 17(6):334-40. PubMed ID: 17767379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The orthostatic tachycardia syndrome: evaluation of autonomic function and treatment with octreotide and ergot alkaloids.
    Hoeldtke RD; Davis KM
    J Clin Endocrinol Metab; 1991 Jul; 73(1):132-9. PubMed ID: 2045464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of octreotide on experimental orthostatic neurogenic hypotension].
    Verwaerde P; Bordet R; Portolan G; Tran MA; Marques MA; Montastruc JL; Sénard JM
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1097-1101. PubMed ID: 8949386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of orthostatic hypotension with dihydroergotamine and caffeine.
    Hoeldtke RD; Cavanaugh ST; Hughes JD; Polansky M
    Ann Intern Med; 1986 Aug; 105(2):168-73. PubMed ID: 3729199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postural hypotension: pressor effect of octreotide not mediated by norepinephrine.
    Weiss M; Shaeffer Z; Eisenstein Z
    South Med J; 1990 Nov; 83(11):1315-7. PubMed ID: 2237563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide in the management of orthostatic hypotension in multiple system atrophy: pilot trial of chronic administration.
    Bordet R; Benhadjali J; Libersa C; Destée A
    Clin Neuropharmacol; 1994 Aug; 17(4):380-3. PubMed ID: 9316686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
    Ramirez CE; Okamoto LE; Arnold AC; Gamboa A; Diedrich A; Choi L; Raj SR; Robertson D; Biaggioni I; Shibao CA
    Hypertension; 2014 Dec; 64(6):1235-40. PubMed ID: 25185131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide for orthostatic hypotension.
    Lamarre-Cliche M; Cusson J
    Can J Clin Pharmacol; 1999; 6(4):213-5. PubMed ID: 10601755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe orthostatic hypotension with the somatostatin analogue octreotide.
    Woo J; Or KH; Teoh R; Nicholls MG
    Aust N Z J Med; 1990 Dec; 20(6):822-3. PubMed ID: 2291734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration.
    Bordet R; Benhadjali J; Destée A; Belabbas A; Libersa C
    Clin Neuropharmacol; 1995 Feb; 18(1):83-9. PubMed ID: 8665540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the somatostatin analogue, octreotide, on exercise-induced hypotension in human subjects with chronic sympathetic failure.
    Smith GD; Alam M; Watson LP; Mathias CJ
    Clin Sci (Lond); 1995 Oct; 89(4):367-73. PubMed ID: 7493436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995.
    Hoeldtke RD; O'Dorisio TM; Boden G
    Lancet; 1986 Sep; 2(8507):602-5. PubMed ID: 2875321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the somatostatin analogue SMS-201-995 on the adrenergic response to glucose ingestion in patients with postprandial hypotension.
    Hoeldtke RD; Dworkin GE; Gaspar SR; Israel BC; Boden G
    Am J Med; 1989 Jun; 86(6 Pt 1):673-7. PubMed ID: 2658575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.
    Biaggioni I; Freeman R; Mathias CJ; Low P; Hewitt LA; Kaufmann H;
    Hypertension; 2015 Jan; 65(1):101-7. PubMed ID: 25350981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide reduces alcohol-induced hypotension and orthostatic symptoms in primary autonomic failure.
    Chaudhuri KR; Thomaides T; Watson L; Mathias CJ
    QJM; 1995 Oct; 88(10):719-25. PubMed ID: 7493169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of propranolol in the treatment of idiopathic orthostatic hypotension.
    Chobanian AV; Volicer L; Liang CS; Kershaw G; Tifft C
    Trans Assoc Am Physicians; 1977; 90():324-34. PubMed ID: 611664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of the somatostatin analogue, octreotide, on postural hypotension, before and after food ingestion, in primary autonomic failure.
    Armstrong E; Mathias CJ
    Clin Auton Res; 1991 Jun; 1(2):135-40. PubMed ID: 1822761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.